These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1120 related articles for article (PubMed ID: 30922063)

  • 1. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
    Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
    Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of VEGF-B-Induced Endocardial Endothelial Cell Lineage in Physiological Versus Pathological Cardiac Hypertrophy.
    Sultan I; Ramste M; Peletier P; Hemanthakumar KA; Ramanujam D; Tirronen A; von Wright Y; Antila S; Saharinen P; Eklund L; Mervaala E; Ylä-Herttuala S; Engelhardt S; Kivelä R; Alitalo K
    Circ Res; 2024 May; 134(11):1465-1482. PubMed ID: 38655691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
    Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
    Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
    Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
    Benedito R; Rocha SF; Woeste M; Zamykal M; Radtke F; Casanovas O; Duarte A; Pytowski B; Adams RH
    Nature; 2012 Mar; 484(7392):110-4. PubMed ID: 22426001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascularization via activation of VEGF-VEGFR signaling is essential for peripheral nerve regeneration.
    Nishida Y; Yamada Y; Kanemaru H; Ohazama A; Maeda T; Seo K
    Biomed Res; 2018; 39(6):287-294. PubMed ID: 30531158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic reduction of vascular endothelial growth factor receptor 2 rescues aberrant angiogenesis caused by epsin deficiency.
    Tessneer KL; Pasula S; Cai X; Dong Y; McManus J; Liu X; Yu L; Hahn S; Chang B; Chen Y; Griffin C; Xia L; Adams RH; Chen H
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):331-337. PubMed ID: 24311377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling.
    Dugaucquier L; Feyen E; Mateiu L; Bruyns TAM; De Keulenaer GW; Segers VFM
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H443-H455. PubMed ID: 32618511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.
    Stepanova V; Jayaraman PS; Zaitsev SV; Lebedeva T; Bdeir K; Kershaw R; Holman KR; Parfyonova YV; Semina EV; Beloglazova IB; Tkachuk VA; Cines DB
    J Biol Chem; 2016 Jul; 291(29):15029-45. PubMed ID: 27151212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac myocyte p38α kinase regulates angiogenesis via myocyte-endothelial cell cross-talk during stress-induced remodeling in the heart.
    Rose BA; Yokota T; Chintalgattu V; Ren S; Iruela-Arispe L; Khakoo AY; Minamisawa S; Wang Y
    J Biol Chem; 2017 Aug; 292(31):12787-12800. PubMed ID: 28637870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation.
    Bry M; Kivelä R; Holopainen T; Anisimov A; Tammela T; Soronen J; Silvola J; Saraste A; Jeltsch M; Korpisalo P; Carmeliet P; Lemström KB; Shibuya M; Ylä-Herttuala S; Alhonen L; Mervaala E; Andersson LC; Knuuti J; Alitalo K
    Circulation; 2010 Oct; 122(17):1725-33. PubMed ID: 20937974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium.
    Kaza E; Ablasser K; Poutias D; Griffiths ER; Saad FA; Hofstaetter JG; del Nido PJ; Friehs I
    Cardiovasc Res; 2011 Feb; 89(2):410-8. PubMed ID: 20935166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.
    Shibuya M
    J Biochem Mol Biol; 2006 Sep; 39(5):469-78. PubMed ID: 17002866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cell-by-cell profiling reveals the temporal dynamics of VEGFR1 and VEGFR2 membrane localization after murine hindlimb ischemia.
    Imoukhuede PI; Dokun AO; Annex BH; Popel AS
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(8):H1085-93. PubMed ID: 23376830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
    Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
    Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
    Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased myocardial stiffness activates cardiac microvascular endothelial cell via VEGF paracrine signaling in cardiac hypertrophy.
    Shen J; Xie Y; Liu Z; Zhang S; Wang Y; Jia L; Wang Y; Cai Z; Ma H; Xiang M
    J Mol Cell Cardiol; 2018 Sep; 122():140-151. PubMed ID: 30138627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic VEGF
    Ganta VC; Choi M; Farber CR; Annex BH
    Circulation; 2019 Jan; 139(2):226-242. PubMed ID: 30586702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.
    Wu J; Strawn TL; Luo M; Wang L; Li R; Ren M; Xia J; Zhang Z; Ma W; Luo T; Lawrence DA; Fay WP
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):111-20. PubMed ID: 25378411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAZF, a novel component of cullin3-based E3 ligase complex, mediates VEGFR and Notch cross-signaling in angiogenesis.
    Ohnuki H; Inoue H; Takemori N; Nakayama H; Sakaue T; Fukuda S; Miwa D; Nishiwaki E; Hatano M; Tokuhisa T; Endo Y; Nose M; Higashiyama S
    Blood; 2012 Mar; 119(11):2688-98. PubMed ID: 22279058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.